FATTY LIVER IN THE PATIENTS WITH HYPERLIPIDEMIA, OBESITY AND DIABETES MELLITUS
DOI:
https://doi.org/10.5457/ams.v37i1.59Keywords:
Ultrasound of the liver, fatty liver, diabetes, cholesterol, triglyceridesAbstract
Introduction: "The fatty liver†is over collection of fat (triglycerides) inside of the liver cells leads to middle increased liver. Non-alcoholic steatohepatitis appears at the patients with pathological level of the lipids in their blood, at the diabetic patients, and at the obese patients. The safest method for diagnosis of the fatty liver is biopsy of the liver, but the ultrasound of the liver is also very objective method for diagnosis. The goal of the research was to find connection between pathological ultrasound of liver (fatty liver) and pathological levels cholesterol, triglycerides, sugar in the blood of all of the patients. The patients and Methods: There were 170 of the patients in the trans-section study (57 of the men (33.50%) and 113 of the women (66.50%). The patients were divided in two groups: a) experimental group with the patients with pathological level of lipids in their blood (32 of the men, and 59 of the women), and b) control group with the patients with normal values of the lipids in their blood (25 of the men, and 54 of the women). Criteria for excluding from research are: the patients under age of 30 years. Cholesterol, triglycerides, sugar, ultrasound of liver was determined in all patients. Results and Discussion: There were 40 of the patients with pathological ultrasound in experimental group, and 11 of the patients with pathological ultrasound in control group (P<0.0001). Conclusion: The patients with pathological levels of lipids in their serum have fatty liver, as a pathological ultrasound finding.
Downloads
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
